Krystal Biotech Inc
(NAS:KRYS)
$
201.58
4.06 (2.06%)
Market Cap: 5.79 Bil
Enterprise Value: 5.24 Bil
PE Ratio: 55.08
PB Ratio: 6.90
GF Score: 36/100 Krystal Biotech Inc (KRYS) Transcripts
- Q2 2024 Krystal Biotech Inc Earnings Call TranscriptAug 05, 2024$180.71 (-5.85%)Earnings
- Q1 2024 Krystal Biotech Inc Earnings Call TranscriptMay 06, 2024$156.94 (-2.58%)Earnings
- Q4 2023 Krystal Biotech Inc Earnings Call TranscriptFeb 26, 2024$157 (+41.02%)Earnings
- Q3 2023 Krystal Biotech Inc Earnings Call TranscriptNov 06, 2023$103.77 (-15.05%)Earnings
- Krystal Biotech Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Krystal Biotech Inc Research & Development Oncology Program Announcement Call TranscriptJul 27, 2023
- Krystal Biotech Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Krystal Biotech Inc at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Krystal Biotech Inc FDA Approval Call TranscriptMay 19, 2023
- Krystal Biotech Inc, Affyimmune Therapeutics Inc, Rocket Pharmaceuticals Inc and Iovance Biotherapeutics Inc at Endpoints Webinar on Moving CGTx Clinical Development- Panel TranscriptMar 02, 2023
- Krystal Biotech Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Krystal Biotech Inc and Jeune Aesthetics Inc PEARL-1 Extension Cohort Results and the KB301 Clinical Development Program - Corporate Call TranscriptNov 17, 2022
- Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Krystal Biotech Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Krystal Biotech Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) TranscriptMar 31, 2022
- Krystal Biotech Inc AAD GEM-3 Phase 3 Data Corporate Call TranscriptMar 28, 2022
- Krystal Biotech Inc KB301 Phase 1 POC Efficacy Data Update Call TranscriptMar 22, 2022
- Krystal Biotech Inc GEM-3 Phase 3 Topline Data Update Call TranscriptNov 29, 2021
- Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Krystal Biotech Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Krystal Biotech Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Krystal Biotech Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Krystal Biotech Inc Annual Shareholders Meeting TranscriptMay 29, 2020
- Krystal Biotech Inc Phase 1/2 Clinical Trial of KB103 Final Update Call TranscriptOct 29, 2019
- 1